Andrew Freese

Title: Innovations in Drug Delivery: The Contributions of Andrew Freese

Introduction

Andrew Freese is an accomplished inventor based in Jamaica Plain, MA (US). He holds a total of 3 patents that focus on advanced drug delivery systems. His work primarily addresses the challenges associated with delivering therapeutic agents to the central nervous system (CNS).

Latest Patents

One of Freese's notable patents is the "Polymeric device for controlled drug delivery to the CNS." This invention describes a polymeric drug delivery system designed to implant directly into the CNS. The system allows for the continuous delivery of substances, such as dopamine, which cannot cross the blood-brain barrier. The implantable devices are engineered to provide controlled, 'zero-order' release kinetics, ensuring a prolonged therapeutic effect. They are particularly relevant for treating various CNS disorders, including Parkinson's disease, Alzheimer's dementia, and epilepsy.

Another significant patent is the "Extended drug delivery of small, water-soluble molecules." This polymeric device is capable of releasing biologically active materials in a controlled and continuous manner over an extended period. The device is designed to be biocompatible and implantable, making it suitable for medical applications. It utilizes a modified approach to prior art devices, allowing for the diffusion of water-soluble molecules into a fluid environment while maintaining the integrity of the polymer matrix.

Career Highlights

Freese has had a distinguished career, contributing to significant advancements in drug delivery technologies. He has worked with prestigious institutions, including the Massachusetts Institute of Technology, where he has furthered his research and development efforts.

Collaborations

Throughout his career, Freese has collaborated with notable individuals in the field, including Bernhard A. Sabel and William Mark Saltzman. These collaborations have enriched his research and contributed to the success of his innovations.

Conclusion

Andrew Freese's contributions to drug delivery systems represent a significant advancement in medical technology. His innovative approaches to addressing CNS disorders through polymeric devices highlight the potential for improved therapeutic outcomes. His work continues to inspire future research in the field of drug delivery.